BiotechTube
Home/Belenos Biosciences/Megan Dow, Ph.D.
MD

Megan Dow, Ph.D.

COO & Co-Founder

Belenos Biosciences

Therapeutic Areas

AsthmaAtopic DermatitisCOPDChronic Rhinosinusitis with Nasal Polyps (CRSwNP)Chronic Spontaneous Urticaria (CSU)Food AllergyScleroderma

Belenos Biosciences Pipeline

DrugIndicationPhase
BEL512Asthma, Atopic Dermatitis, COPD, CRSwNP, CSUIND Enabling
BEL536Atopic Dermatitis, Food Allergy, SclerodermaIND Enabling

Leadership Team at Belenos Biosciences

DM
Donnie McGrath, M.D., M.P.H.
CEO & Co-Founder
TD
Tania Dimitrova, M.B.A.
CFO & Co-Founder
GR
Glenn Rosen, M.D.
Chief Translational Officer & Co-Founder
NV
Nick Vrolijk, Ph.D.
Head of Manufacturing
AR
Anna Rightmire
Head of Clinical Operations
View full Belenos Biosciences profile